University of Toronto Transfusion Medicine Rounds

BiTE and CAR-T cells – expected impact on transfusion

When
Where
Virtual

Event details

Presented by

Dr. Abi Vijenthira

Hematologist & Clinician Investigator, Princess Margaret Cancer Centre

Learning objectives

  1. To understand the rationale for use of CAR-T therapy and bispecific antibodies in patients with lymphoma
  2. To explore the etiology of cytopenias and hypogammaglobulinemia in this population
  3. To understand the volume of transfusion use in these patients
  4. To understand the prognostic impact of transfusion use
  5. To learn about clinical trials in this space to improve our understanding and use of blood products

Registration

Registration is required for this event. To receive registration details for upcoming U of T Transfusion Medicine Rounds directly, join the U of T Transfusion Medicine mailing list via Ontario Regional Blood Coordinating Network (list-manage.com). 

For additional event details about all U of T Transfusion Medicine Rounds, refer to the Ontario Regional Blood Coordinating Network (ORBCoN) website: https://transfusionontario.org/en/events/.